Total Payments
$961,826
2024 Payments
$19,208
Companies
40
Transactions
295
Medicare Patients
1,294
Medicare Billing
$169,295
Payment Breakdown by Category
Consulting$546,744 (56.8%)
Research$305,257 (31.7%)
Other$50,322 (5.2%)
Travel$48,775 (5.1%)
Food & Beverage$10,728 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $546,744 | 54 | 56.8% |
| Unspecified | $305,257 | 5 | 31.7% |
| Travel and Lodging | $48,775 | 61 | 5.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,573 | 24 | 4.9% |
| Food and Beverage | $10,728 | 149 | 1.1% |
| Honoraria | $2,750 | 2 | 0.3% |
Payments by Type
General
$656,569
290 transactions
Research
$305,257
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $797,724 | 88 | $0 (2024) |
| Eisai Inc. | $54,159 | 58 | $0 (2024) |
| Medical Device Business Services, Inc. | $34,352 | 22 | $0 (2021) |
| BK Medical Holding Company Inc. | $12,825 | 3 | $0 (2022) |
| Galil Medical Inc. | $12,665 | 8 | $0 (2019) |
| Covidien LP | $9,320 | 10 | $0 (2020) |
| Boston Scientific Corporation | $9,023 | 8 | $0 (2018) |
| Biocompatibles, Inc. | $6,662 | 2 | $0 (2019) |
| Merck Sharp & Dohme LLC | $5,648 | 11 | $0 (2023) |
| ONQUALITY PHARMACEUTICALS (USA) LLC | $5,257 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,208 | 19 | AngioDynamics, Inc. ($18,921) |
| 2023 | $88,429 | 47 | AngioDynamics, Inc. ($87,133) |
| 2022 | $71,856 | 48 | AngioDynamics, Inc. ($44,807) |
| 2021 | $74,605 | 31 | AngioDynamics, Inc. ($47,470) |
| 2020 | $78,966 | 29 | AngioDynamics, Inc. ($56,658) |
| 2019 | $216,184 | 67 | AngioDynamics, Inc. ($152,967) |
| 2018 | $203,328 | 37 | AngioDynamics, Inc. ($184,282) |
| 2017 | $209,249 | 17 | AngioDynamics, Inc. ($205,485) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Oncology | ||||||
| 10/31/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $71.92 | General |
| Category: OS | ||||||
| 10/31/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: OS | ||||||
| 10/29/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Consulting Fee | Cash or cash equivalent | $6,600.00 | General |
| Category: OS | ||||||
| 10/25/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: OS | ||||||
| 09/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes Care | ||||||
| 07/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/20/2024 | Ethicon US, LLC | DERMABOND (Device) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Wound Closure | ||||||
| 05/24/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Consulting Fee | Cash or cash equivalent | $6,600.00 | General |
| Category: OS | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.96 | General |
| 05/08/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Oncology | ||||||
| 02/27/2024 | AngioDynamics, Inc. | SOLERO (Device) | Food and Beverage | In-kind items and services | $125.74 | General |
| Category: OS | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Oncology | ||||||
| 02/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $72.48 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: OS | ||||||
| 12/08/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Consulting Fee | Cash or cash equivalent | $25,900.00 | General |
| Category: OS | ||||||
| 12/08/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | Cash or cash equivalent | $184.89 | General |
| Category: OS | ||||||
| 11/01/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | In-kind items and services | $152.75 | General |
| Category: OS | ||||||
| 11/01/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | In-kind items and services | $152.75 | General |
| Category: OS | ||||||
| 10/30/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $74.62 | General |
| Category: OS | ||||||
| 10/30/2023 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Surgical Stapling | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Registry on Pancreas/Liver IRE | AngioDynamics, Inc. | $300,000 | 3 |
| A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients (NOVA-II) | ONQUALITY PHARMACEUTICALS (USA) LLC | $5,257 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 340 | 472 | $152,659 | $41,644 |
| 2022 | 6 | 263 | 404 | $97,684 | $31,444 |
| 2021 | 11 | 335 | 512 | $160,858 | $40,504 |
| 2020 | 17 | 356 | 486 | $240,957 | $55,702 |
Total Patients
1,294
Total Services
1,874
Medicare Billing
$169,295
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 64 | $16,256 | $5,369 | 33.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 49 | $12,397 | $4,457 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 52 | $13,208 | $3,873 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $9,261 | $3,589 | 38.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 58 | $10,150 | $3,516 | 34.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $10,824 | $3,480 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 26 | $9,067 | $2,843 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 46 | $7,912 | $2,805 | 35.5% |
| 36561 | Insertion of central venous tube with port (5 years or older) | Facility | 2023 | 12 | 12 | $32,088 | $2,669 | 8.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,800 | $2,427 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 33 | 47 | $8,084 | $2,237 | 27.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $6,396 | $1,796 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,680 | $1,222 | 26.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,984 | $1,196 | 30.0% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2023 | 12 | 12 | $552.00 | $165.60 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 91 | $23,250 | $7,560 | 32.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 88 | $15,400 | $4,711 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 67 | $11,524 | $4,366 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 30 | $10,439 | $3,881 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $8,970 | $2,675 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $7,380 | $2,416 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 31 | $7,874 | $2,316 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 27 | 47 | $8,167 | $2,283 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $4,680 | $1,235 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 105 | $26,806 | $9,307 | 34.7% |
About Dr. Robert Martin, MD
Dr. Robert Martin, MD is a Surgery healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619947504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Martin, MD has received a total of $961,826 in payments from pharmaceutical and medical device companies, with $19,208 received in 2024. These payments were reported across 295 transactions from 40 companies. The most common payment nature is "Consulting Fee" ($546,744).
As a Medicare-enrolled provider, Martin has provided services to 1,294 Medicare beneficiaries, totaling 1,874 services with total Medicare billing of $169,295. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Surgical Oncology
- Location Louisville, KY
- Active Since 01/24/2006
- Last Updated 07/30/2009
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1619947504
Products in Payments
- NANOKNIFE (Device) $243,616
- Nanoknife (Device) $100,000
- Lenvima (Drug) $54,159
- NanoKnife (Device) $47,470
- ECHELON FLEX Stapler (Device) $24,658
- ICEFX (Device) $12,665
- THERASPHERE - BIO (Device) $6,662
- bk3000, bk3500 & bk5000 Ultrasound System (Device) $5,850
- RF 3000 (Device) $5,844
- Echelon Flex (Device) $5,630
- SURGICEL NU-KNIT (Device) $3,395
- SIR-Spheres Microspheres (Device) $2,750
- CERTUS 140 MICROWAVE ABLATION SYSTEM (Device) $2,564
- GENERAL - EMBOLICS (Device) $2,500
- IMFINZI (Biological) $2,162
- HealthMyne (Device) $1,847
- KEYTRUDA (Biological) $984.83
- THERAPIES (Device) $679.18
- Emprint (Device) $312.48
- CREON (Drug) $209.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Louisville
Amit Dwivedi, Md, MD
Surgery — Payments: $447,775
Surgery $447,775
Dr. John Oldham, M.d, M.D
Surgery — Payments: $425,648
Surgery $425,648
Gary Vitale, Md, MD
Surgery — Payments: $93,087
Surgery $93,087
Jared Davis, M.d, M.D
Surgery — Payments: $86,406
Surgery $86,406
Dr. Bryce Schuster, M.d, M.D
Surgery — Payments: $84,271
Surgery $84,271
Dr. John Olsofka, M.d, M.D
Surgery — Payments: $76,398
Surgery $76,398